BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32798341)

  • 21. The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Dec; 9(2):128-33. PubMed ID: 17319344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART).
    Kim JH; Psevdos G; Gonzalez E; Singh S; Kilayko MC; Sharp V
    Infection; 2013 Apr; 41(2):545-51. PubMed ID: 23264096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania.
    Bwana V; Tenu F; Magesa SM; Mfinanga SG
    Tanzan J Health Res; 2011 Jan; 13(1):14-20. PubMed ID: 24409642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and associated factors of thrombocytopenia among HAART-naive HIV-positive patients at Gondar University Hospital, northwest Ethiopia.
    Wondimeneh Y; Muluye D; Ferede G
    BMC Res Notes; 2014 Jan; 7():5. PubMed ID: 24387326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda.
    Kyeyune R; Saathoff E; Ezeamama AE; Löscher T; Fawzi W; Guwatudde D
    BMC Infect Dis; 2014 Sep; 14():496. PubMed ID: 25209550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.
    Morgello S; Estanislao L; Simpson D; Geraci A; DiRocco A; Gerits P; Ryan E; Yakoushina T; Khan S; Mahboob R; Naseer M; Dorfman D; Sharp V;
    Arch Neurol; 2004 Apr; 61(4):546-51. PubMed ID: 15096404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal Function Impairment and Associated Factors among HAART Naïve and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study.
    Mekuria Y; Yilma D; Mekonnen Z; Kassa T; Gedefaw L
    PLoS One; 2016; 11(8):e0161180. PubMed ID: 27537338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
    Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
    Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia.
    Hailu GG; Wasihun AG
    BMC Infect Dis; 2021 Jun; 21(1):561. PubMed ID: 34118891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada.
    Lourenço L; Samji H; Nohpal A; Chau W; Colley G; Lepik K; Barrios R; Lima V; Hogg RS; Montaner J; Kesselring S; Moore DM
    HIV Med; 2015 Jul; 16(6):337-45. PubMed ID: 25721157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria.
    Jegede FE; Oyeyi TI; Abdulrahman SA; Mbah HA; Badru T; Agbakwuru C; Adedokun O
    PLoS One; 2017; 12(3):e0174233. PubMed ID: 28346490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of affordable screening markers to detect CD4+ T-cell counts below 200 cells/mul among HIV-1-infected Ugandan adults.
    Miiro G; Nakubulwa S; Watera C; Munderi P; Floyd S; Grosskurth H
    Trop Med Int Health; 2010 Apr; 15(4):396-404. PubMed ID: 20180936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distal sensory polyneuropathy in HIV-positive patients in the HAART era: an entity underestimated by clinical examination.
    Skopelitis EE; Kokotis PI; Kontos AN; Panayiotakopoulos GD; Konstantinou K; Kordossis T; Karandreas N
    Int J STD AIDS; 2006 Jul; 17(7):467-72. PubMed ID: 16820077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality and progression to AIDS after starting highly active antiretroviral therapy.
    van Sighem AI; van de Wiel MA; Ghani AC; Jambroes M; Reiss P; Gyssens IC; Brinkman K; Lange JM; de Wolf F;
    AIDS; 2003 Oct; 17(15):2227-36. PubMed ID: 14523280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
    Gedefaw L; Yemane T; Sahlemariam Z; Yilma D
    PLoS One; 2013; 8(8):e72202. PubMed ID: 23977253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.
    Eyeson JD; Tenant-Flowers M; Cooper DJ; Johnson NW; Warnakulasuriya KA
    J Oral Pathol Med; 2002 Mar; 31(3):169-74. PubMed ID: 11903824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/AIDS in a poor resource setting: observation from India.
    Chakraborty A; Mahapatra T; Mahapatra S; Ansari S; Siddhanta S; Banerjee S; Banerjee D; Sarkar RN; Guha SK; Chakraborty N
    PLoS One; 2015; 10(2):e0117466. PubMed ID: 25679798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.